AstraZeneca agreed to buy US-based Alexion Pharmaceuticals, as it diversifies into rare-diseases and immunology drugs
⚕️ How Much is Treating Rare Diseases Worth?
⚕️ How Much is Treating Rare Diseases Worth?
⚕️ How Much is Treating Rare Diseases Worth?
AstraZeneca agreed to buy US-based Alexion Pharmaceuticals, as it diversifies into rare-diseases and immunology drugs